Skip to main content
Log in

Evaluation of the Hepatoprotective Effect of L-Ascorbate 1-(2-Hydroxyethyl)-4,6-Dimethyl-1,2-Dihydropyrimidine-2-One Upon Exposure to Carbon Tetrachloride

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Hepatoprotective properties of a new pyrimidine derivative — L-ascorbate 1-(2-hydroxyethyl)-4,6-dimethyl-1,2-dihydropyrimidine-2-one, synthesized on the basis Xymedon, were assessed in white rats exposed to CCl4. The compound under study administered prior to exposure to CCl4 reduced the deviation of biochemical parameters from reference values and severity of structural and morphological changes in liver, when compared to the control. Hepatoprotective properties of the studied compound were more pronounced than those of Xymedon.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Vyshtakalyuk AB, Nazarov NG, Zueva IV, Lantsova AV, Minnekhanova OA, Busygin DV, Porfiryev AG, Evtyugin VG, Reznik VS, Zobov VV. Study of hepatoprotective effects of xymedon.Bull. Exp. Biol. Med. 2013;155(5):643-646.

    Article  CAS  PubMed  Google Scholar 

  2. Vyshtakaliuk AB, Zueva IV, Minnechanova OA, Reznik VS, Zobov VV, Nicolskyi EE, Nazarov NG, Porfiriev AG, Mayatina OV. The influence of the Xymedon preparation (Hydroxyethyldimethyldihydropyrimidine) on the rat liver recovery under toxic damage induced by carbon tetrachloride. Doklady Biochem. Biophysics. 2015;462(1):143-146.

    Article  CAS  Google Scholar 

  3. Zobov VV, Nazarov NG, Vyshtakalyuk AB, Galyametdinova IV, Semenov VE, Reznik VS. Efficiency of new pyrimidine derivativs influence on physical working capacity of rats in the test “swimming to failure”. Ekol. Cheloveka. 2015(1):28-35. Russian.

    Google Scholar 

  4. Myshkin VA, Enikeyev DA. Oxymethyluracil and experimental pathology of the liver. Med. Vestn. Bashkortastana. 2009;4(2):147-151. Russian.

    Google Scholar 

  5. Novikov VE, Klimkina EI. Pharmacology of hepatoprotectors. Obzory po Klin. Farmakol. Lek. Ter. 2005;4(1):2-20. Russian.

    Google Scholar 

  6. Pogorel’tsev VI, Garmonov SJ, Reznik VS, Shitova NS, Jakovleva AV. Patent RF No. 2316327. Ximedon as inductor of human liver microsomal oxidase activity. Bull. No. 4. Published February 10, 2008.

  7. Manual on Experimental (Preclinical) Study of New Pharmacological Substances, Khabriev RU, ed. Moscow, 2005. P. 685. Russian.

  8. Taouk AN, Fiodorov VN, Kunitsa ZA, Smirnov NA, Kotshneva NV. Comparative efficacy of drugs of different pharmacotherapeutic groups in experimental toxic hepatitis. Ros. Med.-Biol. Vestn. 2010(1):66-73. Russian.

    Google Scholar 

  9. Krutikov VI, Ashkinazi RI. Patent US 6730787 B1. 2,4-Dioxo-5-arylidenimino-1,3-pyrimidines. Date of Patent May 04, 2004.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. B. Vyshtakalyuk.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 162, No. 9, pp. 322-325, September, 2016

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vyshtakalyuk, A.B., Nazarov, N.G., Zobov, V.V. et al. Evaluation of the Hepatoprotective Effect of L-Ascorbate 1-(2-Hydroxyethyl)-4,6-Dimethyl-1,2-Dihydropyrimidine-2-One Upon Exposure to Carbon Tetrachloride. Bull Exp Biol Med 162, 340–342 (2017). https://doi.org/10.1007/s10517-017-3610-8

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-017-3610-8

Key Words

Navigation